药店弄虚作假，“双罚”都要到位

Group 1 - The case involved a pharmaceutical company in Baotou City, Inner Mongolia, where the legal representative was found selling counterfeit traditional Chinese medicine, resulting in profits exceeding 10,000 yuan [1] - The prosecutor's office decided not to prosecute due to the minor nature of the crime, considering factors such as self-reporting, confession, and full restitution of illegal gains [1] - The prosecutor's office initiated a reverse connection procedure to ensure administrative oversight following the decision not to prosecute, aiming to prevent a lack of punishment for the wrongdoing [1] Group 2 - The pharmaceutical company faced a potential fine of 1.5 million yuan under drug management laws, which could threaten its survival and employee jobs [2] - A public hearing was organized to discuss the appropriateness of administrative penalties, emphasizing the need to balance legal authority with the survival of the business [2] - The hearing concluded that penalties should consider various factors, including social harm, subjective fault, profit from the crime, and the ability to bear responsibility [2] Group 3 - In October 2025, the market regulatory bureau imposed a fine of 150,000 yuan on the company, which served to penalize the illegal actions while preventing the company from facing excessive fines that could lead to its closure [3] - The legal representative received a lifetime ban from the industry, reflecting the seriousness of the offense while still allowing the company to continue operations [3] - The prosecutor's office recommended that the market regulatory bureau conduct special inspections and educational activities for pharmacies to enhance industry self-discipline [3]